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Objective: Unmodified reperfusion without cardioplegia in minimally
invasive direct coronary artery bypass grafting procedures causes
endothelial dysfunction that may predispose to polymorphonuclear neu-
trophil-mediated myocardial injury. This study tested the hypothesis
that ischemic preconditioning in a minimally invasive direct coronary
artery bypass grafting model attenuates postischemic endothelial dys-
function in coronary vessels. Methods: In anesthetized dogs, the left ante-
rior descending coronary artery was occluded for 30 minutes and reper-
fused for 3 hours without ischemic preconditioning (no-ischemic
preconditioning; n = 7); in 7 dogs, the left anterior descending occlusion
was preceded by 5 minutes occlusion followed by 5 minutes of reperfu-
sion. Relaxation responses to stimulators of nitric oxide synthase were
used to evaluate endothelial function in arteries from the ischemic-
reperfused (left anterior descending) and nonischemic (left circumflex
coronary artery) zones. Results: Stimulated endothelial-dependent relax-
ation of epicardial left anterior descending artery to incremental con-
centrations of acetylcholine in the no-ischemic preconditioning animals
was shifted to the right, and maximal relaxation was attenuated com-
pared with the nonischemic left circumflex coronary artery (117% ± 4%
vs 138% ± 5%). In contrast, acetylcholine-induced maximal relaxation
was comparable in the left anterior descending artery versus left cir-
cumflex coronary artery in the ischemic preconditioning group (130% ±
6% vs 135% ± 5%). In 150- to 200-µm left anterior descending
microvessels, 50% relaxation occurred with a lower concentration
(log[M]) of acetylcholine in ischemic preconditioning versus no-ischemic
preconditioning (–8.0 ± 0.4 vs –7.0 ± 0.1) with no group differences in
smooth muscle relaxation to sodium nitroprusside, suggesting endothe-
lial-specific damage. Adherence of fluorescent labeled polymorphonu-
clear neutrophils to epicardial coronary artery endothelium, used as an
index of basal (unstimulated) anti–polymorphonuclear neutrophil func-
tion, was significantly attenuated by ischemic preconditioning versus
no-ischemic preconditioning (293 ± 25 polymorphonuclear neu-
trophils/mm2 vs 528 ± 29 polymorphonuclear neutrophils/mm2).
Conclusion: In this minimally invasive direct coronary artery bypass
grafting model, both agonist-stimulated and basal postischemic
endothelial dysfunction were attenuated by ischemic preconditioning.
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ISCHEMIC PRECONDITIONING ATTENUATES POSTISCHEMIC CORONARY ARTERY ENDOTHELIAL
DYSFUNCTION IN A MODEL OF MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS 
GRAFTING
I n 1986, Murry and colleagues1 reported a reductionin myocardial necrosis after repeat periods of
ischemia and reperfusion in an in vivo canine model of
transient coronary occlusion. Since this report, a
plethora of studies have observed and characterized the
“ischemic preconditioning” phenomenon. Ischemic
preconditioning (IP) has been defined as an endoge-
nous adaptation of the heart to a prolonged ischemic
insult by exposing the myocardium to a brief period of
ischemia before the prolonged event. IP has been found
to ameliorate regional contractile dysfunction in some
models,2 ischemic contracture,2 infarct size,1,3 and
reperfusion arrhythmias.4 Although the mechanisms of
IP have not been clearly defined, the exogenous infu-
sion of adenosine,5 noradrenaline,6 bradykinin,7 nitric
oxide,8 and endothelin9 before the occlusive event have
been shown to mimic IP. Furthermore, protein kinase C
and adenosine triphosphate–sensitive potassium chan-
nel–mediated mechanisms have been suggested as like-
ly end-effectors that lead to myocardial protection.10,11
Ischemia-reperfusion has been demonstrated to
reduce vascular endothelial-dependent vasoactive prop-
erties in both in vitro12 and in vivo13 animal models.
Injury to vascular endothelium increases polymor-
phonuclear neutrophil (PMN) adherence (basal func-
tion) and decreases the ability of coronary vessels to
vasorelax in response to agonist stimulators of nitric
oxide synthase (stimulated function). Although thera-
peutic strategies (adenosine, nitric oxide) have attenu-
ated PMN attachment and PMN-mediated damage to
the endothelium at reperfusion,14,15 few studies have
examined IP’s potential protective effects on the coro-
nary endothelium, and the results of these studies are
discrepant.16-20 DeFily and Chilian17 have reported that
IP reduces endothelial dysfunction of coronary arteri-
oles in intact beating canine hearts after reperfusion
injury. In contrast, Bauer and colleagues,20 in an in vivo
canine model, have shown that IP did not reduce
endothelium-dependent coronary vasorelaxation. There-
fore the effects of preconditioning on the endothelial
cell have not been clearly defined. Furthermore,
because coronary epicardial macrovessels and micro-
vessels differ in their normal physiologic features and
responses to ischemia and reperfusion,21 with the
microvascular endothelium being more vulnerable to
injury, further studies on the effects of IP on the
endothelium in both vascular tissues are warranted. 
The present study tests the hypothesis that IP attenu-
ates postischemic endothelial dysfunction in epicardial
macrovessels and microvessels in a model of minimally
invasive direct coronary artery bypass grafting (MID-
CABG) in which short-term occlusions simulate tran-
sient intraoperative vessel occlusion during anastomosis.
Methods
General. All dogs were handled in compliance with the
“Guide for the Care and Use of Laboratory Animals” pub-
lished by the National Institutes of Health (NIH Publication
#86-23, revised in 1985) and the Institutional Animal Care
and Use Committee of Emory University.
Fourteen heartworm-free dogs of either sex were initially
anesthetized with pentobarbital (20 mg/kg) and endotracheally
intubated. Anesthesia was supplemented with fentanyl citrate
(0.3 µg/kg/min) and diazepam (0.03 µg/kg/min) administered
intravenously as needed to maintain deep anesthesia. The
dogs were ventilated with a volume-cycled respirator with
oxygen-enriched room air. Serial arterial blood gases were
measured to maintain the arterial oxygen tension above 100
mm Hg and arterial carbon dioxide tension between 30 and
40 mm Hg. A standard lead II electrocardiogram was moni-
tored throughout the experimental protocol. Polyethylene
catheters were inserted into the right femoral artery and vein.
A median sternotomy incision was used to expose the
heart. Millar catheter-tipped pressure transducers (Millar
Instruments, Houston, Texas) were placed in the proximal
aorta and left ventricular cavity to measure aortic and left
ventricular pressures, respectively. The left anterior descend-
ing (LAD) coronary artery distal to the first marginal branch
was dissected and loosely encircled with 2-0 silk suture. 
The dogs were randomized to a 2-group paradigm compar-
ing preconditioning and no-preconditioning involving 30
minutes of LAD occlusion and 3 hours of reperfusion, as
described previously.22 In the group without IP (no-IP), the
LAD artery was occluded for 30 minutes and reperfused for
3 hours. In the preconditioning group (IP), animals under-
went 5 minutes of LAD occlusion followed by 5 minutes of
reperfusion and then 30 minutes of LAD occlusion. After 3
hours of reperfusion, the experiment was terminated with a
bolus of intravenous pentobarbital (100 mg/kg). The heart
was immediately excised and placed into ice-cold Krebs-
Henseleit buffer of the following composition: 118 mmol/L
NaCl, 4.7 mmol/L KCl, 1.2 mmol/L KH2PO4, 1.2 mmol/L
MgSO4 · 7H2O, 2.5 mmol/L CaCl2 · 2H2O, 12.5 mmol/L
NaHCO3, and 11 mmol/L glucose at pH 7.4. After excision of
the coronary artery segments in selected experiments, the
hearts were sliced transversely and incubated in 1% tri-
phenyltetrazolium chloride solution (37°C) for 10 minutes to
visualize necrotic myocardium within the area at risk.
Necrosis was not observed by triphenyltetrazolium chloride
staining. Three ex vivo bioassays were used to interrogate the
effects of in vivo IP on endothelial function.
Neutrophil-endothelial cell adhesion studies
Neutrophil isolation. Neutrophil isolation was performed
with techniques previously described.14 Briefly, peripheral
arterial blood was sampled from the femoral artery before the
median sternotomy and PMNs were isolated by the Ficoll-
Pacque (Sigma Chemical, St. Louis, Mo) density gradient
technique. In our hands, the isolated cell preparation contains
greater than 95% PMNs, and cell viability is greater than
90% (trypan blue exclusion).14
Neutrophil adherence to coronary artery endothelium. The
adherence of unstimulated neutrophils to canine epicardial
coronary arteries was assessed with neutrophils labeled with
Zynaxis PKH26 vital fluorescent dye (Zynaxis Cell Science,
Malvern, Pa). In validation studies performed with the label-
ing procedure, unlabeled and labeled neutrophils demonstrat-
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ed 95% and 97% viability, respectively, using trypan blue
excision.14
After the experiment, LAD (ischemic-reperfused LAD) and
left circumflex coronary artery (LCx; nonischemic LCx) seg-
ments were isolated after the heart was harvested, cut into 3-
mm segments, and carefully opened to expose the endotheli-
um while being submerged in ice-cold Krebs-Henseleit buffer.
The segments were then placed in dishes containing Krebs-
Henseleit buffer at 37°C. Unstimulated, fluorescent-labeled
neutrophils were added to the baths containing the artery seg-
ments (final concentration 1 · 106 cells/dish) for 15 minutes.
After incubation, coronary segments were washed of nonad-
herent PMNs by carefully being dipped in Krebs-Henseleit
buffer 3 times. The segments were mounted on glass slides,
and adherent neutrophils were counted under epifluorescence
microscopy (490-nm excitation; 504-nm emission). 
Agonist-stimulated vascular relaxation
MACROVESSEL STUDIES. Vasoreactivity in epicardial macro-
vessels was interrogated as described previously.14 Briefly,
LAD and LCx segments were carefully transected into 2- to
3-mm rings and placed into organ chambers (Radnoti Glass,
Monrovia, Calif) containing oxygenated (95% oxygen and
5% carbon dioxide) Krebs-Henseleit solution at 37°C.
Indomethacin (10 µmol/L) was used to inhibit the release of
prostaglandins.14 The coronary rings were precontracted with
an optimal concentration of thromboxane A2 mimetic agent,
U-46619, determined for each experiment (approximately 5
nmol/L). Endothelial function was assessed by comparing the
vasorelaxation responses with incremental concentrations of
acetylcholine (10 to 685 µmol/L) and A23187 (1-91 µmol/L),
whereas smooth muscle responses were assessed with sodi-
um nitroprusside (1-381 µmol/L). The order of dilator agent
administration was random, except for A23187, which was
always administered last because this causes the acute loss of
responsiveness to other endothelial agonists.
MICROVESSEL STUDIES. Coronary microvessels were studied
as previously described.23 Briefly, 1 or 2 myocardial arterial
microvessels (150-200 m m in internal diameter) were dissect-
ed from the LAD distribution within the ischemic zone. The
vessels were placed in a circulating organ bath (Krebs-
Henseleit buffer, 37°C), cannulated with dual glass micro-
pipettes, and secured with monofilament suture. The micro-
vessels were pressurized to 20 mm Hg in a no-flow state.
With an inverted microscope connected to a video camera
(IX50-S8F; Olympus Optical Company, Ltd, Japan), the ves-
sel was projected onto a television monitor. A video dimen-
sion analyzer (Halern; Living Systems Instrumentation,
Burlington, Vt), with edge detection algorithms, was used to
measure internal lumen diameter.
After 60 minutes of equilibration, the microvessels were
preconstricted with U-46619 (5 nmol/L) and dilated in a
dose-response fashion with acetylcholine (1 · 10-10–3 · 10-5
mol/L), A23187 (1 · 10-10–3 · 10-5 mol/L), or sodium nitro-
prusside (1 · 10-10–3 · 10-5 mol/L). The order of dilator agent
administration was random, except for A23187, which was
always administered last.
Chemical preparation. Acetylcholine chloride, the calci-
um ionophore A23187, sodium nitroprusside, and indo-
methacin were obtained from Sigma Chemical Company (St
Louis, Mo). The final concentrations of acetylcholine,
A23187, sodium nitroprusside, indomethacin, and U-46619
were determined from a previous study.14 The thromboxane
A2 mimetic, U-46619, was donated from Upjohn Pharma-
ceuticals, Inc (Kalamazoo, Mich). Ca2+- and Mg2+-free
Hanks’ balanced salt solution 1X was purchased from Cellgro
(Mediatech, Inc, Herndon, Va). 
Statistical analysis. An 1-way analysis of variance was
used to determine whether group-related differences oc-
curred. If significant interactions were found, Tukey’s or
Student-Newman-Keuls post hoc multiple comparisons tests
were applied to locate the sources of differences. The mean ±
standard error of the mean are reported. 
Results
Neutrophil adherence to coronary endothelium.
After the experiment, unstimulated, fluorescent-labeled
neutrophils were coincubated with epicardial coronary
arterial segments from both the ischemic-reperfused
LAD artery and the nonischemic-reperfused LCx (Fig
1). In the no-IP group, neutrophil adherence was sig-
nificantly greater by 29% in the LAD segments as com-
pared with the LCx segments (528 ± 29 vs 409 ± 25
neutrophils/mm2, respectively; P = .004). In contrast,
in the ischemic-preconditioned group neutrophil adher-
ence in the ischemic-reperfused LAD coronary seg-
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Fig 1. Adherence of neutrophils to coronary artery endotheli-
um with IP or no-IP. Labeled neutrophils were quantified
with epifluorescence microscopy and are represented as the
sum of neutrophils adhering to the endothelial surface per
square millimeter of endothelium. Values are mean ± stan-
dard error of the mean.
ments was comparable to that observed in the nonis-
chemic-reperfused LCx segments of the same group
and was reduced by 44% compared with no-IP LAD
segments (293 ± 25 vs 528 ± 29 neutrophils/mm2,
respectively; P < .001).
Macrovessel reactivity studies. To quantify agonist-
stimulated endothelial dysfunction in conduit epicar-
dial coronary arteries, we used incremental concentra-
tions of the vasodilators acetylcholine, A23187, and
sodium nitroprusside in the vascular ring preparation.
Fig 2 shows vasodilator responses to acetylcholine in
the isolated coronary rings, expressed as a percentage
of U46619-induced precontraction. In the no-IP group
(Fig 2, A), there is a general and significant right shift
in the concentration-response curve with significantly
lower relaxation responses at acetylcholine concentra-
tions greater than 10 nmol/L compared with the nonis-
chemic LCx group. In addition, there is a significant
decrease in maximal relaxation in the ischemic-LAD
response as compared with the nonischemic LCx
response. Conversely, there is no difference in the con-
centration-response curve and maximal relaxation in
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Fig 2. Response curves to incremental concentrations of
acetylcholine (ACh) to coronary macrovessels precontracted
with U46619, which were treated with no-IP (A) or IP (B).
Responses are expressed as percent relaxation from precon-
tracted tension. Values are mean ± standard error of the mean.
The number of coronary rings in each group is given in
parentheses. *P < .05 versus LCx.
Fig 3. Response curves to incremental concentrations of
acetylcholine (ACh; A), calcium ionophore (A23187; B), and
sodium nitroprusside (NP; C) to LAD microvessels (150-200
µmol/L) precontracted with U46619, which were treated with
no-IP or IP. Responses are expressed as percent relaxation
from precontracted tension. Values are mean ± standard error
of the mean. The number of microvessels in each group is
given in parentheses. *P < .05 versus no-IP.
A
B
C
the IP group between the ischemic-reperfused LAD
and nonischemic LCx segments (Fig 2, B). However,
the median effective concentration (EC50; log[M]), the
concentration of acetylcholine required to effect 50%
relaxation, was not significant between the no-IP and
IP LAD vessels (–7.21 ± 0.04 vs –7.21 ± 0.06, respec-
tively). Maximal responses and EC50 to the endotheli-
um-dependent receptor-independent calcium iono-
phore A23187 and to the smooth muscle-dependent
vasodilator sodium nitroprusside (Table I) showed no
significant difference between LAD and LCx in either
the no-IP or IP groups. Therefore endothelial dysfunc-
tion in epicardial vessels appears to be endothelial cell-
receptor specific. 
Microvessel reactivity studies. In the IP group,
relaxation responses to acetylcholine were significantly
greater at each concentration compared with responses
in the no-IP microvessels, with maximal relaxation
being significantly greater in IP than no-IP microvessels
(Fig 3, A). EC50 (log[M]) in the IP LAD vessels was sig-
nificantly lower than in no-IP LAD vessels (–8.0 ± 0.36
vs –7.02 ± 0.14, respectively; P = .035). Although there
is a modest trend toward lower relaxation responses to
nonreceptor mediated A23187, there is no significant
difference in maximal relaxation between IP and no-IP
LAD vessels (Fig 3, B) or EC50 (–8.63 ± 0.39 vs –8.13
± 0.19, respectively; P = .263). Maximal relaxation to
the endothelium-independent vasodilator, sodium nitro-
prusside, was significantly greater in the IP group at
selected concentrations (Fig 3, C), and EC50 was signif-
icantly lower in the IP-treated LAD vessels as compared
with the no-IP treated vessels (–8.42 ± 0.26 vs –7.21 ±
0.29, respectively; P = .023).
Discussion
In the present study, we sought to determine whether
IP could attenuate postischemic endothelial dysfunc-
tion in a canine MIDCABG model in which a period of
short-term vessel occlusion is obligatory during coro-
nary artery anastomosis. A recent study by Bufkin and
colleagues22 demonstrated contractile dysfunction in
the ischemic-reperfused myocardium after the primary
occlusion, which was immune to the effects of IP. In
contrast, the present study demonstrates that 30 min-
utes of LAD occlusion followed by reperfusion attenu-
ated the basal antineutrophil and agonist-stimulated
components of endothelial function in the ischemic-
reperfused epicardial macrovessels, although vasore-
laxation responses were also impaired in the microves-
sels. Injury to the endothelium by myocardial ischemia
and reperfusion increased neutrophil adherence (basal
response) and decreased the ability of coronary vessels
to vasorelax (stimulated response) to agonist stimula-
tion of nitric oxide synthase. IP attenuated endothelial
dysfunction in both epicardial coronary macrovessels
and microvessels and significantly decreased the adher-
ence of neutrophils to ischemic-reperfused LAD
endothelium. In addition, IP reversed moderate smooth
muscle dysfunction observed in ischemic-reperfused
microvessels. These data suggest that IP may attenuate
macrovascular and microvascular endothelial dysfunc-
tion and inhibit neutrophil-endothelial cell interactions,
although contractile dysfunction in the area at risk may
not be attenuated based on a previous study.22
Since the initial report of IP by Murry and col-
leagues,1 a considerable amount of literature regarding
this phenomenon has been published focusing primari-
ly on the end points of contractile function and infarct
size. Although IP reduces myocyte necrosis resulting
from a prolonged ischemia, the effects of precondition-
ing on the coronary vascular endothelium is less well
defined. In 1993, DeFily and Chilian,17 measuring
vasodilator reserve in in vivo canine coronary arteri-
oles, demonstrated that IP preserved endothelial-
dependent vasodilation after myocardial ischemia-
reperfusion. Similar endothelial protection with IP was
reported by Richard and colleagues.18 Conversely,
Bauer and colleagues20 reported that although IP sig-
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Table I. Macrovessel responses to A23187 and sodium nitroprusside
A23187 Sodium nitroprusside
Maximal relaxation (%) EC50 log[M] Maximal relaxation (%) EC50 log[M]
No-IP
LAD 128 ± 4.0 –7.77 ± 0.04 111 ± 2.3 –7.34 ± 0.03
LCx 134 ± 3.8 –7.76 ± 0.06 120 ± 2.6 –7.40 ± 0.03
IP
LAD 142 ± 5.0 –7.80 ± 0.03 121 ± 5.1 –7.33 ± 0.03
LCx 141 ± 5.8 –7.84 ± 0.04 125 ± 4.8 –7.39 ± 0.03
The values are mean ± standard error of the mean.
nificantly reduced myocardial infarct size, the protec-
tive effects did not extend to the coronary endothelium
because IP did not significantly improve postischemic
endothelium-dependent responses to acetylcholine.
More recently, Kaeffer and colleagues16 showed that
endothelial dysfunction as the result of ischemia-reper-
fusion persisted for at least 1 month and that IP attenu-
ated this prolonged endothelial dysfunction. The pre-
sent study showed that IP preserved acute endothelial
function in both epicardial coronary macrovessels and
microvessels in agreement with DeFily and Chilian17
and others16,18-20 and extended these observations by
demonstrating a reduction in neutrophil adherence with
IP. However, it is not known whether endothelial dys-
function in postischemic macrovessels and microves-
sels is a long-term event in this MIDCABG model, or
whether IP offers sustained protection. 
It is well established that under basal conditions, nor-
mal endothelium releases nitric oxide, which acts to
tonically retard the adherence of neutrophils to coro-
nary endothelium. In response to myocardial ischemia-
reperfusion, the ability to synthesize and release nitric
oxide is impaired in relation to the degree of endothe-
lial injury, which leads to increased basal neutrophil
adherence and reduced vascular relaxation responses to
agonist stimulators of nitric oxide synthase. In our
study, we demonstrated that myocardial stunning
increases basal neutrophil-coronary endothelial adher-
ence in ischemic LAD when compared with the neu-
trophil-endothelial adherence in the nonischemic LCx.
Although it is well established that the interaction
between PMN and coronary vascular endothelium at
reperfusion leads to endothelial dysfunction,24,25 which
can largely be attenuated by anti-PMN therapy (nitric
oxide, adenosine, monoclonal antibodies),14,15,26 it is
not clear from our study whether IP reduced endothe-
lial dysfunction by directly protecting the endothelium
or by directly attenuating neutrophil activation and
adherence. If the preconditioning response is mediated,
in part by adenosine, then both cell types may be effect-
ed directly. However, it would be interesting to deter-
mine whether endothelial protection by IP involved
attenuation of neutrophil events at reperfusion.
Nevertheless, the protection afforded to the endotheli-
um is manifested in part by inhibiting PMN adherence. 
Study limitations. Although the beneficial effects of
IP have not been found in all species, many studies
have reported the beneficial effects of IP in both canine
and human patients. It is possible that the degree of
injury and the effectiveness of IP may be blunted in
human patients.27 The effects of IP on human myo-
cardium may depend on whether the ischemia is local
(ie, coronary occlusion) or global. In addition, our stud-
ies were performed in normal coronary vessels. How-
ever, in instances where underlying pathologic condi-
tions such as atherosclerosis, diabetes mellitus, or
hypercholesterolemia may significantly impact the
ability of the endothelium to produce endogenous pro-
tection with ischemic or chemical preconditioning, the
protection afforded by preconditioning may be less
than in normal vessels. Further studies interrogating the
effects of IP on endothelial function in humans under-
going coronary artery bypass grafting are warranted.
Another consideration is the clinical relevance of the
duration of LAD occlusion used in the present study. In
a large study of MIDCABG procedures, the time to
completion of target vessel anastomosis averaged 23
minutes.28 In the present study, the duration of region-
al ischemia (30 minutes) is only somewhat longer than
that encountered during completion of anastomoses in
MIDCABG operations. Whether shorter periods of
coronary occlusion in patients with underlying disease
causes endothelial dysfunction needs to be determined.
In summary, the present study used a canine model of
transient coronary occlusion to evaluate the effect of IP
on coronary artery endothelium. We conclude that IP
attenuated endothelial dysfunction expressed as neu-
trophil adherence to the ischemic-reperfused LAD and
attenuated endothelial dysfunction in both coronary
macrovessels and microvessels, which may have impli-
cations for the long-term patency of grafts and myocar-
dial viability. Furthermore, we have demonstrated that
IP reduces neutrophil adherence to vascular endotheli-
um, which is consistent with an attenuation of neu-
trophil accumulation in ischemic-reperfused areas at
risk observed in a previous study with the same
model.22 This study may be clinically important for the
practicing cardiac surgeon, because protection of coro-
nary vascular endothelial function by IP may diminish
reperfusion injury, reduce vascular permeability and
myocardial edema, and possibly reduce end-artery
thrombosis and its associated complications. 
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